Europe — EMA
Milgamma (Benfotiamine, Cyanocobalamin)
GNH USA supplies Milgamma (Benfotiamine, Cyanocobalamin), a supplement for thiamine and cobalamin deficiencies and neuropathy support. Request a quote.
Request sourcing
What is Benfotiamine, Cyanocobalamin?
Benfotiamine and Cyanocobalamin, the active ingredients in Milgamma, are vitamin supplements presented as an oral formulation for oral use. They provide vitamin B1 (thiamine) and vitamin B12 (cobalamin) to support carbohydrate metabolism, red blood cell formation, and neuronal function, helping to correct deficiencies and associated neuropathic symptoms and may be used under medical supervision.
GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured batches and reliable logistics for global healthcare providers.
What is Benfotiamine, Cyanocobalamin used for?
Milgamma, a combined vitamin B1 and B12 supplement, is used to address conditions related to thiamine and cobalamin deficiency and associated neuropathies. - Thiamine deficiency: restores adequate vitamin B1 levels to support carbohydrate metabolism. - Cobalamin deficiency: supplies vitamin B12 for DNA synthesis, red blood cell formation, and nerve health. - Peripheral neuropathy: helps alleviate symptoms of nerve damage, including diabetic neuropathy support.
What are the side effects of Benfotiamine, Cyanocobalamin?
Milgamma is generally well tolerated, but some users may experience adverse reactions.
Common Side Effects: - Nausea: mild stomach upset after oral intake. - Abdominal discomfort: occasional cramping or bloating. - Headache: transient mild headache. - Diarrhea: loose stools in sensitive individuals. - Skin rash: mild erythema or itching. - Metallic taste: temporary alteration in taste perception.
Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Stevens‑Johnson syndrome: rare severe skin eruption. - Hematologic abnormalities: pancytopenia or severe anemia. - Severe hypersensitivity: swelling of face, lips, or tongue. - Thrombotic events: extremely rare clotting disorders.
What precautions apply to Benfotiamine, Cyanocobalamin?
Before initiating Milgamma, consider the following safety measures. - Assess deficiency status: confirm thiamine or cobalamin deficiency through laboratory testing. - Monitor blood counts: especially in patients with existing hematologic disorders. - Use with caution in renal impairment: adjust dosing if renal function is compromised. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep below 25 °C in the original pack, protect from moisture and heat.
What does Benfotiamine, Cyanocobalamin interact with?
Milgamma may interact with certain medicines; awareness helps prevent reduced efficacy or adverse effects.
Major Interactions (Avoid): - Metformin: may mask vitamin B12 deficiency, requiring regular monitoring. - Chloramphenicol: can interfere with folate‑dependent pathways, potentially affecting B12 utilization.
Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may decrease B12 absorption over long‑term use. - Oral contraceptives: can increase the requirement for B vitamins. - Alcohol: excessive intake raises thiamine needs and may diminish therapeutic benefit.



